ArticleArthritis research & therapy2023

Janus kinase inhibitor, tofacitinib, in refractory juvenile dermatomyositis: a retrospective multi-central study in China.

Junmei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.